HomeNGNE • NASDAQ
add
Neurogene Inc
Previous close
$11.36
Day range
$10.80 - $11.96
Year range
$6.88 - $74.49
Market cap
158.09M USD
Avg Volume
328.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | — |
Operating expense | 62.57M | 35.89% |
Net income | -19.51M | -918.88% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -20.81M | -49.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 312.40M | 58.45% |
Total assets | 335.73M | 50.84% |
Total liabilities | 25.36M | -30.63% |
Total equity | 310.38M | — |
Shares outstanding | 14.93M | — |
Price to book | 0.54 | — |
Return on assets | -21.62% | — |
Return on capital | -22.83% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -19.51M | -918.88% |
Cash from operations | -17.50M | -3.09% |
Cash from investing | -102.62M | -497.27% |
Cash from financing | 190.06M | 101.56% |
Net change in cash | 69.95M | -32.19% |
Free cash flow | -9.94M | -351.35% |
About
Founded
2018
Website
Employees
107
